Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza a virus hemagglutinin

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Roedig, Jana Verena ^a   Rapp, Erdmann ^a   Höper, Dirk ^b   Genzel, Yvonne ^a   Reichl, Udo ^a,c  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; GLYCOPROTEIN; HEMAGGLUTININ; INFLUENZA VACCINE; POLYSACCHARIDE; VIRUS HEMAGGLUTININ; VIRUS RNA;

ADAPTATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CELL STRAIN; CONTROLLED STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; NONHUMAN; PROTEIN GLYCOSYLATION; PYROSEQUENCING; SPECIES COMPARISON; VERO CELL; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CERCOPITHECUS; CHEMISTRY; DNA SEQUENCE; DOG; GENETICS; GLYCOSYLATION; HUMAN; IMMUNOLOGY; METABOLISM; MUTATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DOGS; GLYCOPROTEINS; GLYCOSYLATION; HEMAGGLUTININS; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; MODELS, BIOLOGICAL; MUTATION; POLYSACCHARIDES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VERO CELLS;

EID: 82855172168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027989     Document Type: Article

References (54)

1. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y, (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
2. Lin YP, Wharton SA, Martin J, Skehel JJ, Wiley DC, et al. (1997) Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology 233: 402-410.
3. Hirst GK, (1947) Studies on the Mechanism of Adaptation of Influenza Virus to Mice. J Exp Med 86: 357-366.
4. Webster RG, Laver WG, Air GM, Schild GC, (1982) Molecular mechanisms of variation in influenza viruses. Nature 296: 115-121.
5. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, et al. (2009) Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift. Science 326: 734-736.
6. Rogers GN, Paulson JC, (1983) Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127: 361-373.
7. de Wit E, Munster VJ, van Riel D, Beyer WEP, Rimmelzwaan GF, et al. (2010) Molecular Determinants of Adaptation of Highly Pathogenic Avian Influenza H7N7 Viruses to Efficient Replication in the Human Host. Journal of Virology 84: 1597-1606.
8. Skehel JJ, Wiley DC, (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
9. Wrigley NG, (1979) Electron microscopy of influenza virus. Br Med Bull 35: 35-38.
10. Johansson BE, Bucher DJ, Kilbourne ED, (1989) Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol 63: 1239-1246.
11. Rudd PM, Dwek RA, (1997) Glycosylation: Heterogeneity and the 3D Structure of Proteins. Critical Reviews in Biochemistry and Molecular Biology 32: 1-100.
12. Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, et al. (2004) Effect of the Addition of Oligosaccharides on the Biological Activities and Antigenicity of Influenza A/H3N2 Virus Hemagglutinin. Journal of Virology 78: 9605-9611.
13. Saito T, Nakaya Y, Suzuki T, Ito R, Saito T, et al. (2004) Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. Journal of Medical Virology 74: 336-343.
14. Chen Z, Aspelund A, Jin H, (2008) Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs. Vaccine 26: 361-371.
15. Opitz L, Zimmermann A, Lehmann S, Genzel Y, Lubben H, et al. (2008) Capture of cell culture-derived influenza virus by lectins: Strain independent, but host cell dependent. Journal of Virological Methods 154: 61-68.
16. de Vries RP, de Vries E, Bosch BJ, de Groot RJ, Rottier PJM, et al. (2010) The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity. Virology 403: 17-25.
17. Domingo E, Baranowski E, Ruiz-Jarabo CM, Martin-Hernandez AM, Saiz JC, et al. (1998) Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis 4: 521-527.
18. Domingo E, Sabo D, Taniguchi T, Weissmann C, (1978) Nucleotide sequence heterogeneity of an RNA phage population. Cell 13: 735-744.
19. Biebricher CK, Eigen M, (2006) What is a quasispecies? Curr Top Microbiol Immunol 299: 1-31.
20. Scholtissek C, (1995) Molecular evolution of influenza viruses. Virus Genes 11: 209-215.
21. Kilbourne ED, (1969) Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ 41: 643-645.
22. Steinhauer DA, Holland JJ, (1987) Rapid evolution of RNA viruses. Annu Rev Microbiol 41: 409-433.
23. Domingo E, Martin V, Perales C, Grande-Perez A, Garcia-Arriaza J, et al. (2006) Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol 299: 51-82.
24. Lauring AS, Andino R, (2010) Quasispecies theory and the behavior of RNA viruses. PLoS Pathog 6: e1001005.
25. Gerdil C, (2003) The annual production cycle for influenza vaccine. Vaccine 21: 1776-1779.
26. Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, et al. (2011) The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 29: 1836-1843.
27. Genzel Y, (2004) Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22: 2202-2208.
28. Genzel Y, Dietzsch C, Rapp E, Schwarzer J, Reichl U, (2010) MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Applied Microbiology and Biotechnology 88: 461-475.
29. Kalbfuss B, Knochlein A, Krober T, Reichl U, (2008) Monitoring influenza virus content in vaccine production: Precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals 36: 145-161.
30. Schwarzer J, Rapp E, Reichl U, (2008) N-glycan analysis by CGE-LIF: Profiling influenza A virus hemagglutininN-glycosylation during vaccine production. Electrophoresis 29: 4203-4214.
31. Schwarzer J, Rapp E, Hennig R, Genzel Y, Jordan I, et al. (2009) Glycan analysis in cell culture-based influenza vaccine production: Influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine 27: 4325-4336.
32. Ruhaak LR, Hennig R, Huhn C, Borowiak M, Dolhain RJ, et al. (2010) Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF. J Proteome Res 9: 6655-6664.
33. Hoper D, Hoffmann B, Beer M, (2009) Simple, sensitive, and swift sequencing of complete H5N1 avian influenza virus genomes. J Clin Microbiol 47: 674-679.
34. Leifer I, Hoffmann B, Hoper D, Bruun Rasmussen T, Blome S, et al. (2010) Molecular epidemiology of current classical swine fever virus isolates of wild boar in Germany. J Gen Virol 91: 2687-2697.
35. Hoper D, Hoffmann B, Beer M, (2011) A comprehensive deep sequencing strategy for full-length genomes of influenza a. PLoS ONE 6: e19075.
36. Wiley G, Macmil S, Qu C, Wang P, Xing Y, et al. (2009) Methods for generating shotgun and mixed shotgun/paired-end libraries for the 454 DNA sequencer. Curr Protoc Hum Genet Chapter 18: Unit18 11.
37. Gamblin SJ, (2004) The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin. Science 303: 1838-1842.
38. Ruigrok RW, Wrigley NG, Calder LJ, Cusack S, Wharton SA, et al. (1986) Electron microscopy of the low pH structure of influenza virus haemagglutinin. EMBO J 5: 41-49.
39. Ruigrok RW, Martin SR, Wharton SA, Skehel JJ, Bayley PM, et al. (1986) Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology 155: 484-497.
40. Doms RW, Gething MJ, Henneberry J, White J, Helenius A, (1986) Variant influenza virus hemagglutinin that induces fusion at elevated pH. J Virol 57: 603-613.
41. Reed ML, Bridges OA, Seiler P, Kim JK, Yen HL, et al. (2010) The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol 84: 1527-1535.
42. Thoennes S, Li ZN, Lee BJ, Langley WA, Skehel JJ, et al. (2008) Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. Virology 370: 403-414.
43. Brown JD, Swayne DE, Cooper RJ, Burns RE, Stallknecht DE, (2007) Persistence of H5 and H7 avian influenza viruses in water. Avian Dis 51: 285-289.
44. Reed ML, Yen HL, DuBois RM, Bridges OA, Salomon R, et al. (2009) Amino Acid Residues in the Fusion Peptide Pocket Regulate the pH of Activation of the H5N1 Influenza Virus Hemagglutinin Protein. Journal of Virology 83: 3568-3580.
45. Wagner R, Heuer D, Wolff T, Herwig A, Klenk HD, (2002) N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. J Gen Virol 83: 601-609.
46. Winter G, Fields S, Brownlee GG, (1981) Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype. Nature 292: 72-75.
47. Schickli JH, Flandorfer A, Nakaya T, Martinez-Sobrido L, Garcia-Sastre A, et al. (2001) Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci 356: 1965-1973.
48. Seitz C, Frensing T, Hoper D, Kochs G, Reichl U, (2010) High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol 91: 1754-1763.
49. Schulze-Horsel J, Schulze M, Agalaridis G, Genzel Y, Reichl U, (2009) Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling. Vaccine 27: 2712-2722.
50. Heynisch B, Frensing T, Heinze K, Seitz C, Genzel Y, et al. (2010) Differential activation of host cell signalling pathways through infection with two variants of influenza A/Puerto Rico/8/34 (H1N1) in MDCK cells. Vaccine 28: 8210-8218.
51. Vester D, Rapp E, Kluge S, Genzel Y, Reichl U, (2010) Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach. J Proteomics 73: 1656-1669.
52. Bull JJ, Badgett MR, Wichman HA, Huelsenbeck JP, Hillis DM, et al. (1997) Exceptional convergent evolution in a virus. Genetics 147: 1497-1507.
53. Rott R, Orlich M, Klenk HD, Wang ML, Skehel JJ, et al. (1984) Studies on the adaptation of influenza viruses to MDCK cells. EMBO J 3: 3329-3332.
54. Klenk HD, Wagner R, Heuer D, Wolff T, (2002) Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res 82: 73-75.